Alliances
Exscientia will use its full-stack AI drug discovery platform, Centaur Chemist, to accelerate the discovery of small molecule therapeutic drug candidates. It will focus on three of Celgene’s therapeutic programs in oncology and autoimmunity.
PDC*line Pharma grants exclusive license in South Korea and exclusive option in other Asian countries to LG Chem Life Sciences Company, for the development and commercialization of PDC*lung cancer vaccine for lung cancer
Biotech and pharma companies from across Europe and Asia provide updates on pipeline and business activities.
The trial, which paired a checkpoint inhibitor and PARP inhibitor, was not likely to hit endpoints. It was the second ovarian cancer trial failure for the two companies in six months.
Alexion Pharmaceuticals announced two big collaboration partnerships today. First, Alexion, headquartered in Boston, and Affibody AB, located in Solna, Sweden, signed a partnership deal to co-develop ABY-039 for Immunoglobulin G (IgG)-mediated autoimmune diseases.
Collaboration explores opportunities to set up antibiotic discovery and development platform and establish a joint pipeline of novel antibiotic assets
In a Phase III trial, a higher proportion of deaths was observed in the venetoclax arm compared to the control arm of the trial.
Karolinska Development’s portfolio company Promimic announces a new partnership with the U.S company Onkos Surgical® to commercialize Promimic’s proprietary Hydroxyapatite Surface Technologies in Limb Salvage Surgery.
The Society for Clinical Research Sites and 4G Clinical announced 4G Clinical has joined the organization as a Global Impact Partner.
MC Services AG, the international public relations and investor relations firm, announced that it will support, as a media partner, BIO-Europe Spring® 2019, Europe’s largest springtime partnering conference for the global life sciences industry.
PRESS RELEASES